Advanced Viral Research Corp., of Yonkers, N.Y., appointed Martin Bookman acting chief financial officer.
Antares Pharma Inc., of Exton, Pa., appointed Rajesh Shrotriya to its board.
Array BioPharma Inc., of Boulder, Colo., appointed Douglas Williams to its board.
BayBio, of South San Francisco, appointed to its board Steven Burrill, Paul Heiden, Bruce Jenett, Gail Maderis, Jennie Mather, Jeffrey Peterson, Glen Sato, Steve Sawyer, Tom Smart and Brad Vale.
Benitec Ltd., of Queensland, Australia, appointed Cy Stein and David Engelke to its scientific advisory board.
BioTrove Inc., of Woburn, Mass., appointed Alan Carter vice president of worldwide sales.
Carolina Pharmaceuticals Inc., of Cary, N.C., appointed Daniel Fisher vice president of business development.
CytRx Corp., of Los Angeles, said its subsidiary CytRx Laboratories, of Worcester, Mass., appointed Michael Czech, Ronald Kahn, Craig Mello, Tariq Rana, Luciano Rosetti and Bruce Spiegelman to its scientific advisory board.
DarPharma Inc., of Chapel Hill, N.C., appointed Michael Knable, Louis Leeburg and Robert Postlethwait to its board; Michael Dombeck director of business development; and Brett Farabaugh vice president of finance.
DeCode genetics Inc., of Reykjavik, Iceland, appointed James Beery to its board.
Erxsys Inc., of Irvine, Calif., appointed Carl Balog to its advisory board.
Genaera Corp., of Plymouth Meeting, Pa., appointed the following to its ophthalmic advisory board: Susan Bressler, Charles Garcia, Glenn Jaffe, Michael Klein, Hugo Quiroz-Mercado, Gholam Peyman, Lawrence Rand, Carl Regillo, Jack Owens and Edgar Thomas.
Genencor International Inc., of Palo Alto, Calif., named Philip Haworth vice president of business development, health care.
Genitope Corp., of Redwood City, Calif., appointed John Vuko vice president of finance and chief financial officer.
Leerink Swann & Co., of Boston, appointed John Sullivan director in the equity research department.